Multiple myeloma with acute light chain cast nephropathy

Abstract Light chain cast nephropathy (LCCN) is a leading cause of acute kidney injury (AKI) in patients with multiple myeloma (MM) and is now defined as a myeloma defining event. While the long-term prognosis has improved with novel agents, short-term mortality remains significantly higher in patie...

Full description

Bibliographic Details
Main Authors: Nelson Leung, S. Vincent Rajkumar
Format: Article
Language:English
Published: Nature Publishing Group 2023-03-01
Series:Blood Cancer Journal
Online Access:https://doi.org/10.1038/s41408-023-00806-w
_version_ 1797854024867774464
author Nelson Leung
S. Vincent Rajkumar
author_facet Nelson Leung
S. Vincent Rajkumar
author_sort Nelson Leung
collection DOAJ
description Abstract Light chain cast nephropathy (LCCN) is a leading cause of acute kidney injury (AKI) in patients with multiple myeloma (MM) and is now defined as a myeloma defining event. While the long-term prognosis has improved with novel agents, short-term mortality remains significantly higher in patients with LCCN especially if the renal failure is not reversed. Recovery of renal function requires a rapid and significant reduction of the involved serum free light chain. Therefore, proper treatment of these patients is of the utmost importance. In this paper, we provide an algorithm for treatment of MM patients who present with biopsy-proven LCCN or in those where other causes of AKI have been ruled out. The algorithm is based on data from randomized trial whenever possible. When trial data is not available, our recommendations is based on non-randomized data and expert opinions on best practices. We recommend that all patients should enroll in a clinical trial if available prior to resorting to the treatment algorithm we outlined.
first_indexed 2024-04-09T20:00:20Z
format Article
id doaj.art-f025813352404bd1a1e219dfe1f26f3b
institution Directory Open Access Journal
issn 2044-5385
language English
last_indexed 2024-04-09T20:00:20Z
publishDate 2023-03-01
publisher Nature Publishing Group
record_format Article
series Blood Cancer Journal
spelling doaj.art-f025813352404bd1a1e219dfe1f26f3b2023-04-03T05:17:14ZengNature Publishing GroupBlood Cancer Journal2044-53852023-03-011311710.1038/s41408-023-00806-wMultiple myeloma with acute light chain cast nephropathyNelson Leung0S. Vincent Rajkumar1Division of Hematology, Mayo ClinicDivision of Hematology, Mayo ClinicAbstract Light chain cast nephropathy (LCCN) is a leading cause of acute kidney injury (AKI) in patients with multiple myeloma (MM) and is now defined as a myeloma defining event. While the long-term prognosis has improved with novel agents, short-term mortality remains significantly higher in patients with LCCN especially if the renal failure is not reversed. Recovery of renal function requires a rapid and significant reduction of the involved serum free light chain. Therefore, proper treatment of these patients is of the utmost importance. In this paper, we provide an algorithm for treatment of MM patients who present with biopsy-proven LCCN or in those where other causes of AKI have been ruled out. The algorithm is based on data from randomized trial whenever possible. When trial data is not available, our recommendations is based on non-randomized data and expert opinions on best practices. We recommend that all patients should enroll in a clinical trial if available prior to resorting to the treatment algorithm we outlined.https://doi.org/10.1038/s41408-023-00806-w
spellingShingle Nelson Leung
S. Vincent Rajkumar
Multiple myeloma with acute light chain cast nephropathy
Blood Cancer Journal
title Multiple myeloma with acute light chain cast nephropathy
title_full Multiple myeloma with acute light chain cast nephropathy
title_fullStr Multiple myeloma with acute light chain cast nephropathy
title_full_unstemmed Multiple myeloma with acute light chain cast nephropathy
title_short Multiple myeloma with acute light chain cast nephropathy
title_sort multiple myeloma with acute light chain cast nephropathy
url https://doi.org/10.1038/s41408-023-00806-w
work_keys_str_mv AT nelsonleung multiplemyelomawithacutelightchaincastnephropathy
AT svincentrajkumar multiplemyelomawithacutelightchaincastnephropathy